Safety Study of GCS-100 to Treat Chronic Kidney Disease
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Bhupinder Singh, MD
Southwest Clinical Research Institute, LLC
Principal Investigator - George Fadda, MD
California Institute of Renal Research
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Southwest Clinical Research Institute
Tempe, Arizona, United States
- California Institue of Renal Research
La Mesa, California, United States
- Denver Nephrologists, Pc
Denver, Colorado, United States
- Renal Associates Pa / Research Division
San Antonio, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 2013
- Primary completion
- 30 Jun 2013
- Completion
- 30 Jun 2013
- Last update posted
- 20 Jun 2013
- Registered enrollment
- 29
- Registry id
- NCT01717248
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.